Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-19

FDA Approved: BIMATOPROST — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved the original ANDA for bimatoprost ophthalmic solution by Sandoz, establishing a generic version of this glaucoma medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

ORIG AP for BIMATOPROST (BIMATOPROST)